Evidence map›Paper›PMID 26829936›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2016

Antioxidative-oxidative balance in epilepsy patients on antiepileptic therapy: a prospective case-control study.

Selda Keskin Guler, Bilal Aytac, Zahide Esra Durak, Burcu Gokce Cokal, Nalan Gunes, Ilker Durak, Tahir Yoldas

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Ellagic acid and allopurinol decrease HExperimental brain research · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Selda Keskin GulerDepartment of Adult Neurology, Ankara Training and Research Hospital, Şükriye District, Ulucanlar Avenue, No: 89, Altındağ, 06340, Ankara, Turkey. keskinselda@gmail.com.
Bilal AytacGeneral Directorate of Health Information Systems, Ministry of Health, Ankara, Turkey.
Zahide Esra DurakThe Laboratory of Turkish Public Health Institution, Ministry of Health, Ankara, Turkey.
Burcu Gokce CokalDepartment of Adult Neurology, Ankara Training and Research Hospital, Şükriye District, Ulucanlar Avenue, No: 89, Altındağ, 06340, Ankara, Turkey.
Nalan GunesDepartment of Adult Neurology, Ankara Training and Research Hospital, Şükriye District, Ulucanlar Avenue, No: 89, Altındağ, 06340, Ankara, Turkey.
Ilker DurakDepartment of Biochemistry, Ankara University Faculty of Medicine, Ankara, Turkey.
Tahir YoldasDepartment of Adult Neurology, Ankara Training and Research Hospital, Şükriye District, Ulucanlar Avenue, No: 89, Altındağ, 06340, Ankara, Turkey.
Ministry of Health · TRAnkara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress has been implicated in various disorders, including epilepsy. The aim of this study was to investigate the oxidant and antioxidant status of patients with epilepsy using antiepileptic drugs regularly and to compare them with healthy subjects. We investigated serum catalase (CAT), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and xanthine oxidase (XO) levels in 58 epilepsy patients and 25 healthy controls. Patients were divided into polytherapy (n = 17) and monotherapy (n = 41) groups, and antioxidant status was compared between the two groups and controls. There was no significant difference between the patient and control groups in terms of age or gender (p > 0.05). The mean duration of illness in the patients was 14.8 years, and the mean duration of treatment was 11.4 years. Comparison of the patient and control groups in terms of oxidative stress and antioxidant defence parameters revealed significantly higher MDA, GSH-Px, XO and lower level of CAT, SOD levels (p < 0.05). There were no differences in CAT, MDA, GSH-Px or SOD levels between the monotherapy and polytherapy groups; but the XO level was higher in the monotherapy group (p < 0.05). Although the XO level was decreased by polytherapy, it was higher than in controls. Our study found significantly low level of antioxidants in patients with epilepsy as compared to control. Thus, antiepileptic treatment did not improve oxidative stress parameters. Furthermore, our results show that polytherapy does not change the situation as compared with monotherapy. Antioxidant replacement therapy may benefit these patients.

Indexed as

AdultAnalysis of VarianceAnticonvulsantsAntioxidantsCase-Control StudiesCatalaseEpilepsyFemaleGlutathione PeroxidaseHumansMaleMalondialdehydeMiddle AgedOxidative StressProspective StudiesSuperoxide DismutaseAnticonvulsantsAntioxidantsCatalaseGlutathione PeroxidaseMalondialdehydeSuperoxide DismutaseXanthine OxidaseAntiepileptic drugsAntioxidant effectMonotherapyOxidative balancePolytherapy

Identifiers

PMID26829936
OpenAlexW2265458343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.